Cardio Renal Syndrome: Peritoneal Ultrafiltration Treatment

We are studying whether Peritoneal Ultrafiltration can help prevent heart failure worsening in patients with Cardio Renal Syndrome. The trial also looks at improvements in health and quality of life.

>2 years6-10 visitsEfficacy phase (II)Confirmation phase (III)No PlaceboInvestigational MedicinesInjectionCardiologyInternal MedicineNephrology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Calcium Chloride Dihydrate
Calcium chloride dihydrate is a substance used to quickly raise low blood calcium levels and help stabilize heart function in emergencies.
Lactic Acid
Lactic acid is a substance used in skincare to gently exfoliate and improve skin texture and hydration.
Levocarnitine
Levocarnitine is a substance that helps the body produce energy by transporting fatty acids into cells and treating carnitine deficiency.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Polydextrose

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
ASST Fatebenefratelli Sacco
Nefrologia e Dialisi
Baranzate, Italy
IRCCS Azienda Ospedaliero Universitaria di Bologna - Policlinico S. Orsola-Malpighi
Nefrologia, dialisi e trapianto
Bologna, Italy
Universita' Degli Studi G. D'annunzio Di Chieti
Nefrologia e Dialisi
Chieti, Italy
Sponsor: Iperboreal Pharma S.r.l.
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.